Alteco Medical offers a medical device for extracorporeal blood purification. The product removes endotoxin (lipopolysaccharide, LPS) from the patient’s bloodstream, and is applied as an add-on therapy in sepsis to treat endotoxemia (high levels of endotoxin). This can help stabilize the patient in acute situations. Endotoxemia is often present in sepsis, a life-threatening condition and one of the most common causes of death in modern intensive care.

Quotes for Alteco Medical AB

Right Now

+/-
0.003
%
1,76%
Latest
0.173
High
0.175
Low
0.17
Volume
128 784
Turnover (SEK)
22 311
Market Value (MSEK)
9,9
Time (Latest trade)

Board

CEO

  • Anders Althin (tf)

Chairperson of the Board

  • Mats Wahlström

Board

  • Anders Althin
  • Charlotte Althin Hicks

Largest Owners

Name Capital % Votes % Date
Anders Althin 90,04 90,04 2024-12-03
Avanza Pension 0,66 0,66 2024-09-26
Gunnar Råbe 0,32 0,32 2024-09-26
Nordnet Pensionsförsäkring 0,32 0,32 2024-09-26
Jarl Ingvar Andersson 0,31 0,31 2024-09-26
Magnus Lundberg 0,28 0,28 2024-09-26
Fredrik Nerme 0,23 0,23 2024-09-26
Handelsbanken Liv Försäkring AB 0,23 0,23 2024-09-26
Britt Kraff 0,19 0,19 2024-09-26
Korosh Fouladi 0,17 0,17 2024-09-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream